![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication October 27, 2005.
Revised January 18, 2006.
Accepted for publication January 18, 2006.
F508-CFTR by curcumin: involvement of the keratin 18 network
The most common mutation in the CFTR gene,
F508, causes retention of
F508-CFTR in the endoplasmic reticulum and leads to the absence of CFTR Cl- channels in the plasma membrane.
F508-CFTR retains some Cl- channel activity so increased expression of
F508-CFTR in the plasma membrane can restore Cl- secretion deficiency. Recently, curcumin was shown to rescue
F508-CFTR localization and function. In our previous work, the keratin 18 network was implicated in
F508-CFTR trafficking. Here, we hypothesized that curcumin could restore a functional
F508-CFTR to the plasma membrane acting via the K18 network. First, we analyzed the effects of curcumin on the localization of
F508-CFTR in different cell lines (HeLa cells stably transfected with WT-CFTR or
F508-CFTR, CALU-3 cells or CF pancreatic epithelial cells CFPAC-1) and found it was significantly delocalized towards the plasma membrane in
F508-CFTR-expressing cells. We also performed a functional assay for the CFTR chloride channel in CFPAC-1 cells treated or not with curcumin and detected an increase in a cAMP-dependent chloride efflux in treated
F508-CFTR-expressing cells. Then, the K18 network was analyzed by immunocytochemistry and immunoblot exclusively in curcumin-treated or untreated CFPAC-1 cells because of their endogenic
F508-CFTR expression. After curcumin treatment, we observed a remodeling of the K18 network and a significant increase in K18 Ser52 phosphorylation, a site directly implicated in the reorganization of intermediate filaments. With these results, we propose K18 as a new therapeutic target and curcumin and/or its analogs might be considered as potential therapeutic agents for cystic fibrosis.
Key words:
CFTR, Cystic Fibrosis, chloride secretion, curcumin, keratin 18, traffic
This article has been cited by other articles:
![]() |
C. Norez, M. Pasetto, M. C. Dechecchi, E. Barison, C. Anselmi, A. Tamanini, F. Quiri, L. Cattel, P. Rizzotti, F. Dosio, et al. Chemical conjugation of {Delta}F508-CFTR corrector deoxyspergualin to transporter human serum albumin enhances its ability to rescue Cl- channel functions Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L336 - L347. [Abstract] [Full Text] [PDF] |
||||